Abstract
RESPONSES to the excitatory amino acid N-methyl-D-aspartate (NMDA) are markedly potentiated by nanomolar concentrations of glycine1–3. This is due to the action of glycine at a novel strychnine-resistant binding site with an anatomical distribution identical to that for NMDA receptors4,5, suggesting that the NMDA receptor channel complex contains at least two classes of amino-acid recognition site. Antagonists at the glycine-binding site associated with NMDA receptors act as potent non-competitive antagonists6,7, but do not alter the mean open time or conductance, as estimated by fluctuation analysis8. The mechanisms by which glycine acts on NMDA receptors are unknown, but single-channel recording experiments show an increase in opening frequency with no change in mean open time or conductance7, suggesting that glycine could regulate transitions to states that are intermediate between binding of NMDA receptor agonists and ion-channel gating. It has been suggested that glycine acts as a co-agonist at the NMDA receptor, and that responses to NMDA cannot be obtained in the complete absence of glycine9, but in these experi-ments the response to NMDA was measured at equilibrium, and it is unlikely that sufficient temporal resolution was achieved to detect rapid alterations in receptor gating. Using a fast perfusion system we find that glycine regulates desensitization at NMDA receptors; this has a major effect on the response to NMDA measured at equilibrium, as would occur with slower applications of agonist. Reduction of NMDA receptor desensitization by glycine provides an example of a novel mechanism for regulation of ion-channel activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johnson, J. W. & Ascher, P. Nature 325, 529–531 (1987).
Verdoorn, T. A., Kleckner, N. W. & Dingledine, R. Science 238, 1114–1116 (1987).
Kushner, L., Lerma, J., Zukin, S. R. & Bennett, M. V. L. Proc. natn. Acad. Sci. U.S.A. 85, 3250–3254 (1988).
Bristow, D. R., Bowery, N. G. & Woodruff, G. N. Eur. J. Pharmac. 126, 303–307 (1986).
Monaghan, D. T. & Cotman, C. W. J. Neurosci. 5, 2909–2919 (1986).
Evans, R. H., Evans, S. J., Pook, S. C. & Sunter, D. C. Br. J. Pharmac. 91, 531–537 (1987).
Kemp, J. A. et al. Proc. natn. Acad. Sci. U.S.A. 85, 6547–6550 (1987).
Mayer, M. L., Westbrook, G. L. & Vyklicky, L. J. Neurophysiol. 60, 645–663 (1988).
Kleckner, N. W. & Dingledine, R. Science 241, 835–837 (1988).
Mayer, M. L. & Vyklicky, L. Proc. natn. Acad. Sci. U.S.A. 86, 1411–1415 (1989).
Johnson, J. W. & Ascher, P. Soc. Neurosci. Abstr. 13, 383 (1987).
Sakmann, B., Patlak, J. & Neher, E. Nature 286, 71–73 (1980).
Feltz, A. & Trautmann, A. J. Physiol. 322, 257–272 (1982).
Mierlak, D. & Farb, D. H. J. Neurosci. 8, 814–820 (1988).
Mayer, M. L. & Westbrook, G. L. J. Physiol. 394, 501–527 (1987).
Mayer, M. L. & Westbrook, G. L. J. Physiol. 361, 65–90 (1985).
Mayer, M. L., MacDermott, A. B., Westbrook, G. L., Smith, S. J. & Barker, J. L. J. Neurosci 7, 3230–3244 (1987).
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. & Prochiantz, A. Nature 307, 462–465 (1984).
Mayer, M. L., Westbrook, G. L. & Guthrie, P. B. Nature 309, 261–263 (1984).
Clapham, D. & Neher, E. J. Physiol. 347, 255–277 (1984).
Forsythe, I. D. & Westbrook, G. L. J. Physiol. 396, 515–533 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mayer, M., Vyklicky, L. & Clements, J. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338, 425–427 (1989). https://doi.org/10.1038/338425a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/338425a0
This article is cited by
-
NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction
Neuroscience Bulletin (2019)
-
Managing Negative Symptoms of Schizophrenia: How Far Have We Come?
CNS Drugs (2017)
-
Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes
Molecular Brain (2015)
-
Novel glycine-dependent inactivation of NMDA receptors in cultured hippocampal neurons
Neuroscience Bulletin (2012)
-
A quantitative method to assess extrasynaptic NMDA receptor function in the protective effect of synaptic activity against neurotoxicity
BMC Neuroscience (2008)